US 8053422
Anti-cancer oligodeoxynucleotides
granted A61KA61K31/7088A61P
Quick answer
US patent 8053422 (Anti-cancer oligodeoxynucleotides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Nov 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/7088, A61P, A61P35/00